Dr. Changsheng Ma (China)
Beijing Anzhen Hospital, Capital Medical University
Chief Physician, Professor
Director of the Cardiology Center, Beijing Anzhen Hospital, Capital Medical University
President of the Chinese Society of Cardiology, Chinese Medical Association
President of the Committee of Remote and Intelligent Management for Chronic Diseases, Chinese Society of Gerontology and Geriatrics
Director of the Engineering Research Center of Ministry of Education for Cardiovascular Diagnosis, Treatment Technologies and Medical Devices
Engaged in the diagnosis, treatment, and research of arrhythmias and atrial fibrillation, as well as the development of domestically produced diagnostic and therapeutic devices. Specializes in the research and development of AI diagnostic and therapeutic technologies for cardiovascular diseases. Has published over 600 research articles in SCI-indexed journals, including Lancet, JAMA, Circulation, JACC, and Nature Reviews Cardiology.
Awarded the National Science and Technology Progress Award (Second Class) three times. Initiated the establishment of the "Cardiovascular Disease Management Capacity Assessment and Improvement Program (CDQI)" and the "Cardiovascular Randomized Controlled Trial Collaboration Group (CRCT)," promoting high-quality training and clinical research in cardiovascular medicine nationwide.
Chief Physician, Professor
Director of the Cardiology Center, Beijing Anzhen Hospital, Capital Medical University
President of the Chinese Society of Cardiology, Chinese Medical Association
President of the Committee of Remote and Intelligent Management for Chronic Diseases, Chinese Society of Gerontology and Geriatrics
Director of the Engineering Research Center of Ministry of Education for Cardiovascular Diagnosis, Treatment Technologies and Medical Devices
Engaged in the diagnosis, treatment, and research of arrhythmias and atrial fibrillation, as well as the development of domestically produced diagnostic and therapeutic devices. Specializes in the research and development of AI diagnostic and therapeutic technologies for cardiovascular diseases. Has published over 600 research articles in SCI-indexed journals, including Lancet, JAMA, Circulation, JACC, and Nature Reviews Cardiology.
Awarded the National Science and Technology Progress Award (Second Class) three times. Initiated the establishment of the "Cardiovascular Disease Management Capacity Assessment and Improvement Program (CDQI)" and the "Cardiovascular Randomized Controlled Trial Collaboration Group (CRCT)," promoting high-quality training and clinical research in cardiovascular medicine nationwide.